Related Experiment Video
Updated: Jul 19, 2026

Dissection and Coronal Slice Preparation of Developing Mouse Pituitary Gland
Published on: November 16, 2017
Expression of Rasd1 in mouse endocrine pituitary cells and its response to dexamethasone
Chad D Foradori1, Laci Mackay1, Chen-Che J Huang1
1Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Abstract:
Dexamethasone-induced Ras-related protein 1 (Rasd1) is a member of the Ras superfamily of monomeric G proteins that have a regulatory function in signal transduction. Rasd1, also known as Dexras1 or AGS1, is rapidly induced by dexamethasone (Dex). While prior data indicates that Rasd1 is highly expressed in the pituitary and that the gene may function in regulation of corticotroph activity, its exact cellular localization in this tissue has not been delineated. Nor has it been determined which endocrine pituitary cell type(s) are responsive to Dex-induced expression of Rasd1. We hypothesized that Rasd1 is primarily localized in corticotrophs and furthermore, that its expression in these cells would be upregulated in response to exogenous Dex administration. Rasd1 expression in each pituitary cell type both under basal conditions and 1-hour post Dex treatment were examined in adult male mice. While a proportion of all endocrine pituitary cell types expressed Rasd1, a majority of corticotrophs and thyrotrophs expressed Rasd1 under basal condition. In vehicle treated animals, approximately 50-60% of corticotrophs and thyrotrophs cells expressed Rasd1 while the gene was detected in only 15-30% of lactotrophs, somatotrophs, and gonadotrophs. In Dex treated animals, Rasd1 expression was significantly increased in corticotrophs, somatotrophs, lactotrophs, and gonadotrophs but not thyrotrophs. In Dex treated animals, Rasd1 was detected in 80-95% of gonadotrophs and corticotrophs. In contrast, Dex treatment increased Rasd1 expression to a lesser extent (55-60%) in somatotrophs and lactotrophs. Corticotrophs of the pars intermedia, which lack glucocorticoid receptors, failed to display increased Rasd1 expression in Dex treated animals. Rasd1 is highly expressed in corticotrophs under basal conditions and is further increased after Dex treatment, further supporting its role in glucocorticoid negative feedback. In addition, the presence and Dex-induced expression of Rasd1 in endocrine pituitary cell types, other than corticotrophs, may implicate Rasd1 in novel pituitary functions.
Insights
Dexamethasone-induced Ras-related protein 1 (Rasd1) is highly expressed in pituitary corticotrophs and increases with dexamethasone (Dex) treatment, supporting its role in glucocorticoid feedback. Rasd1 is also found in other pituitary cells, suggesting new functions.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Dexamethasone-induced Ras-related protein 1 (Rasd1) is a Ras superfamily G protein involved in signal transduction.
- Rasd1 is rapidly induced by dexamethasone (Dex) and highly expressed in the pituitary, potentially regulating corticotroph activity.
- The precise cellular localization and cell-type-specific response to Dex-induced Rasd1 expression in the pituitary remain unclear.
Purpose of the Study:
- To investigate the cellular localization of Rasd1 in different pituitary cell types.
- To determine which pituitary endocrine cell types are responsive to Dex-induced Rasd1 expression.
- To examine the role of Rasd1 in glucocorticoid negative feedback and explore potential novel pituitary functions.
Main Methods:
- Adult male mice were used to examine Rasd1 expression in pituitary cell types.
- Immunohistochemistry was employed to detect Rasd1 expression under basal conditions and 1-hour post-dexamethasone (Dex) or vehicle treatment.
- Quantitative analysis of Rasd1 expression in corticotrophs, thyrotrophs, lactotrophs, somatotrophs, and gonadotrophs was performed.
Main Results:
- Under basal conditions, a majority of corticotrophs and thyrotrophs expressed Rasd1 (50-60%), with lower expression in lactotrophs, somatotrophs, and gonadotrophs (15-30%).
- Dexamethasone (Dex) treatment significantly increased Rasd1 expression in corticotrophs (80-95%), somatotrophs, lactotrophs, and gonadotrophs, but not thyrotrophs.
- Corticotrophs in the pars intermedia, lacking glucocorticoid receptors, did not show increased Rasd1 expression after Dex treatment.
Conclusions:
- Rasd1 is highly expressed in pituitary corticotrophs and its expression is upregulated by dexamethasone (Dex), supporting its role in glucocorticoid negative feedback.
- The presence and Dex-induced expression of Rasd1 in multiple pituitary cell types suggest potential novel functions beyond glucocorticoid regulation.
- Further research is warranted to elucidate the specific roles of Rasd1 in various pituitary endocrine cell types.

